This study will evaluate the effects of tegaserod on orocecal and colonic transit in patients over 65 years with chronic constipation.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
60
Arkansas Gastroenterology, PA
North Little Rock, Arizona, United States
University of Michigan Medical Center
Ann Arbor, Michigan, United States
Temple University Hospital
Philadelphia, Pennsylvania, United States
Orocecal transit: Time of radioactive marker to reach the cecum using scintigraphy
Whole gut transit and stomach emptying: Following 2 weeks of treatment, the rate of transit of food through the colon and stomach will be measured using scintigraphy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.